Top

Published in:

01-10-2017 | Original Paper

Nephrolithiasis as a risk factor of chronic kidney disease: a meta-analysis of cohort studies with 4,770,691 participants

Authors: Meng Zhe, Zheng Hang

Published in: Urolithiasis | Issue 5/2017

Abstract

The objective of the study was to investigate the association between nephrolithiasis and the risk of chronic kidney disease (CKD). PubMed, Embase and ScienceDirect databases were searched for relevant cohort studies. A meta-analysis was conducted by pooling data from these studies via an inverse variance method. The Q statistic and I ² were used to measure heterogeneity. Sensitivity analysis was conducted to ascertain whether the results were stable. Nine studies with eight cohorts involving 4,770,691 participants were identified. Compared to individuals without a history of nephrolithiasis, the pooled relative risk was 1.52 [95% confidence interval (CI) 1.24, 1.68; I ² = 93.7%] for all stages of CKD and 2.16 (95% CI 1.83–2.54; I ² = 0.00%) for end-stage kidney disease. Publication bias was not detected. Sensitivity analysis indicated that the results were stable. Nephrolithiasis may increase the risk of CKD, regardless of the patient population (region), and may be an important risk factor for end-stage kidney disease.

Available only for authorised users

Türk C, Petřík A, Sarica K et al (2016) EAU guidelines on diagnosis and conservative management of urolithiasis. Eur Urol 69(3):468–474CrossRefPubMed

Cheungpasitporn W, Thongprayoon C, Mao MA et al (2014) The risk of coronary heart disease in patients with kidney stones: a systematic review and meta-analysis. N Am J Med Sci 6(11):580–585CrossRefPubMedPubMedCentral

National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1–S266

Chen N, Wang W, Huang Y et al (2009) Community-based study on CKD subjects and the associated risk factors. Nephrol Dial Transplant 24(7):2117–2123CrossRefPubMedPubMedCentral

Ingsathit A, Thakkinstian A, Chaiprasert A et al (2010) Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant 25(5):1567–1575CrossRefPubMed

Vupputuri S, Soucie JM, McClellan W et al (2004) History of kidney stones as a possible risk factor for chronic kidney disease. Ann Epidemiol 14(3):222–228CrossRefPubMed

Marangella M, Bruno M, Cosseddu D et al (1990) Prevalence of chronic renal insufficiency in the course of idiopathic recurrent calcium stone disease: risk factors and patterns of progression. Nephron 4(4):302–306

Hippisley-Cox J, Coupland C (2010) Predicting the risk of chronic kidney disease in men and women in England and Wales: prospective derivation and external validation of the QKidney Scores. BMC Fam Pract 21(11):49CrossRef

Kummer AE, Grams M, Lutsey P et al (2015) Nephrolithiasis as a risk factor for CKD: the atherosclerosis risk in communities study. Clin J Am Soc Nephrol 10(11):2023–2029CrossRefPubMedPubMedCentral

10.

Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264–269CrossRefPubMed

11.

Bekkering GE, Harris RJ, Thomas S et al (2008) How much of the data published in observational studies of the association between diet and prostate or bladder cancer is usable for meta-analysis? Am J Epidemiol 167(9):1017–1026CrossRefPubMed

12.

Wells GA, Shea B, O’Connell D et al (2011) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed Dec 2014

13.

Aune D, Lau R, Chan DSM et al (2011) Nonlinear reduction in risk for colorectal cancer by fruit and vegetable intake based on meta-analysis of prospective studies. Gastroenterology 141(1):16–20CrossRef

14.

Higgins JPT, Green S (2011) Cochrane handbook for systematic reviews of interventions. The Cochrane Collaboration, 5.1.0 edn. http://www.cochrane-handbook.org. Accessed 23 May 2016

15.

Egger M, Davey Smith G, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634CrossRefPubMedPubMedCentral

16.

Rule AD, Bergstralh EJ, Melton LJ et al (2009) Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 4(4):804–811CrossRefPubMedPubMedCentral

17.

El-Zoghby ZM, Lieske JC, Foley RN et al (2012) Urolithiasis and the risk of ESRD. Clin J Am Soc Nephrol 7(9):1409–1415CrossRefPubMedPubMedCentral

18.

Shoag J, Halpern J, Goldfarb DS et al (2014) Risk of chronic and end stage kidney disease in patients with nephrolithiasis. J Urol 192(5):1440–1445CrossRefPubMed

19.

Alexander RT, Hemmelgarn BR, Wiebe N et al (2012) Kidney stones and kidney function loss: a cohort study. BMJ 345:e5287CrossRefPubMedPubMedCentral

20.

D’Costa M, Savcic-Kos R, Huang J et al (2016) Urological procedures in urolithiasis and their association with chronic kidney disease. Clin Med Res 14(2):75–82CrossRefPubMedPubMedCentral

21.

Keller JJ, Chen YK, Lin HC (2012) Association between chronic kidney disease and urinary calculus by stone location: a population-based study. BJU Int 110(11 Pt C):E1074–E1078CrossRefPubMed

22.

Ando R, Nagaya T, Suzuki S et al (2014) MP34-15 increased risk for chronic kidney disease in kidney stone formers: a follow-up study in Japanese. Urolithiasis 6(42):498

23.

Pearle MS, Goldfarb DS, Assimos DG et al (2014) Medical management of kidney stones: AUA guideline. J Urol 192(2):316–324CrossRefPubMed

24.

Türk C, Petřík A, Sarica K et al (2016) EAU guidelines on interventional treatment for urolithiasis. Eur Urol 69(3):475–482CrossRefPubMed

25.

Lieske JC, Peña de la Vega LS, Slezak JM et al (2006) Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int 69(4):760–764CrossRefPubMed

26.

Zhang L, Wang F, Wang L et al (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379(9818):815–822CrossRefPubMed

Title: Nephrolithiasis as a risk factor of chronic kidney disease: a meta-analysis of cohort studies with 4,770,691 participants
Authors: Meng Zhe
Zheng Hang
Publication date: 01-10-2017
Publisher: Springer Berlin Heidelberg
Published in: Urolithiasis / Issue 5/2017
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI: https://doi.org/10.1007/s00240-016-0938-x

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Nephrolithiasis as a risk factor of chronic kidney disease: a meta-analysis of cohort studies with 4,770,691 participants

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2017

Comparative risk of chronic kidney diseases in patients with urolithiasis and urological interventions: a longitudinal population-based study

Kidney stones diseases and glycaemic statuses: focus on the latest clinical evidences

Geographic location is an important determinant of risk factors for stone disease

Whey protein and albumin effects upon urinary risk factors for stone formation

Development of a novel magnetic resonance imaging acquisition and analysis workflow for the quantification of shock wave lithotripsy-induced renal hemorrhagic injury

Fluoroscopy versus ultrasound for image guidance during percutaneous nephrolithotomy: a systematic review and meta-analysis